Australian researchers have discovered the key immunological changes that support the remission of peanut allergy in children, paving the way for new, more targeted treatments.
The research showed for the first time specific gene networks are rewired to drive the transition from peanut allergy to clinical remission following combination treatment of a probiotic and peanut oral immunotherapy.
Led by the Murdoch Children’s Research Institute (MCRI) and the Telethon Kids Institute, the study found that …
